GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Adcock Ingram Holdings Ltd (JSE:AIP) » Definitions » Debt-to-Equity

Adcock Ingram Holdings (JSE:AIP) Debt-to-Equity : 0.05 (As of Jun. 2024)


View and export this data going back to 2008. Start your Free Trial

What is Adcock Ingram Holdings Debt-to-Equity?

Adcock Ingram Holdings's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was R42 Mil. Adcock Ingram Holdings's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was R238 Mil. Adcock Ingram Holdings's Total Stockholders Equity for the quarter that ended in Jun. 2024 was R5,413 Mil. Adcock Ingram Holdings's debt to equity for the quarter that ended in Jun. 2024 was 0.05.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Adcock Ingram Holdings's Debt-to-Equity or its related term are showing as below:

JSE:AIP' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.05   Med: 0.06   Max: 0.28
Current: 0.05

During the past 13 years, the highest Debt-to-Equity Ratio of Adcock Ingram Holdings was 0.28. The lowest was 0.05. And the median was 0.06.

JSE:AIP's Debt-to-Equity is ranked better than
82.34% of 838 companies
in the Drug Manufacturers industry
Industry Median: 0.3 vs JSE:AIP: 0.05

Adcock Ingram Holdings Debt-to-Equity Historical Data

The historical data trend for Adcock Ingram Holdings's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adcock Ingram Holdings Debt-to-Equity Chart

Adcock Ingram Holdings Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.07 0.06 0.06 0.06 0.05

Adcock Ingram Holdings Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.06 0.06 0.06 0.09 0.05

Competitive Comparison of Adcock Ingram Holdings's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Adcock Ingram Holdings's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Adcock Ingram Holdings's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Adcock Ingram Holdings's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Adcock Ingram Holdings's Debt-to-Equity falls into.



Adcock Ingram Holdings Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Adcock Ingram Holdings's Debt to Equity Ratio for the fiscal year that ended in Jun. 2024 is calculated as

Adcock Ingram Holdings's Debt to Equity Ratio for the quarter that ended in Jun. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Adcock Ingram Holdings  (JSE:AIP) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Adcock Ingram Holdings Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Adcock Ingram Holdings's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Adcock Ingram Holdings Business Description

Traded in Other Exchanges
N/A
Address
1 New Road, (c/o New Road & 7th Street), Midrand, Johannesburg, GT, ZAF, 1682
Adcock Ingram Holdings Ltd is a drug manufacturing company. The company manufactures, markets, and distributes a wide range of healthcare products. The company generates roughly two-thirds of its sales from the private sector, with the remaining from the public sector. Adcock operates in four broad areas: renal disease, medicine delivery, transfusion therapies, and blood and specialized pharmaceuticals. The company generates the vast majority of its revenue in southern Africa, followed by the rest of Africa and India.